Anastrozole and reduced risk of breast cancer
Since yesterday (Tuesday 7 th November), various media outlets have been sharing a news story about Anastrozole, a medication that may be offered to tens of thousands of women who are at an increased risk of developing breast cancer. This could be a huge step forward for breast cancer prevention in the UK, and it has generated a large number of conversations across the Online Community around breast cancer treatments. Macmillan Cancer Support have been asked to provide a statement in response to this announcement. Statement from Macmillan Cancer Support Dany Bell, Strategic Adviser for Treatment, Medicines and Genomics at Macmillan Cancer Support, said: “Knowing that you have an increased risk of developing breast cancer can be difficult to deal with, so today’s news about Anastrozole is…